STAAR Surgical Co (STAA) stock
STAANasdaqOphthalmic GoodsFiscal year ends January 2
$26.78+0.09 (+0.34%)
Close on Nov 12, 2026Market cap $1.34BP/E –Yield –
STAAR Surgical EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
STAAR Surgical's EPS for the twelve months ending Oct 2, 2026 was $0.00. For fiscal 2025 it was -$1.62. The highest annual figure on record is $0.80 in fiscal 2022.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | -$1.62 | – |
| FY2024 | Dec 27, 2024 | -$0.41 | -195.3% |
| FY2023 | Dec 29, 2023 | $0.43 | -46.3% |
| FY2022 | Dec 30, 2022 | $0.80 | +42.9% |
| FY2021 | Dec 31, 2021 | $0.56 | +366.7% |
| FY2020 | Jan 1, 2021 | $0.12 | -60.0% |
| FY2019 | Jan 3, 2020 | $0.30 | +172.7% |
| FY2018 | Dec 28, 2018 | $0.11 | – |
| FY2017 | Dec 29, 2017 | -$0.05 | – |
| FY2016 | Dec 30, 2016 | -$0.30 | – |
| FY2015 | Jan 1, 2016 | -$0.17 | – |
| FY2014 | Jan 2, 2015 | -$0.22 | -2300.0% |
| FY2013 | Jan 3, 2014 | $0.01 | – |
| FY2012 | Dec 28, 2012 | -$0.05 | -225.0% |
| FY2011 | Dec 30, 2011 | $0.04 | – |
| FY2010 | Dec 31, 2010 | $0.00 | – |
| FY2009 | Jan 1, 2010 | -$0.19 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Oct 2, 2026 | $0.11 | -38.9% |
| Q2 FY2026 | Jul 3, 2026 | $0.16 | – |
| Q1 FY2026 | Apr 3, 2026 | $0.10 | – |
| Q4 FY2025 | Jan 2, 2026 | -$0.37 | – |
| Q3 FY2025 | Sep 26, 2025 | $0.18 | -10.0% |
| Q2 FY2025 | Jun 27, 2025 | -$0.34 | -326.7% |
| Q1 FY2025 | Mar 28, 2025 | -$1.10 | – |
| Q4 FY2024 | Dec 27, 2024 | -$0.72 | -550.0% |
| Q3 FY2024 | Sep 27, 2024 | $0.20 | +100.0% |
| Q2 FY2024 | Jun 28, 2024 | $0.15 | +25.0% |
| Q1 FY2024 | Mar 29, 2024 | -$0.07 | -240.0% |
| Q4 FY2023 | Dec 29, 2023 | $0.16 | +14.3% |
| Q3 FY2023 | Sep 29, 2023 | $0.10 | -52.4% |
| Q2 FY2023 | Jun 30, 2023 | $0.12 | -53.8% |
| Q1 FY2023 | Mar 31, 2023 | $0.05 | -73.7% |
| Q4 FY2022 | Dec 30, 2022 | $0.14 | +40.0% |
| Q3 FY2022 | Sep 30, 2022 | $0.21 | +75.0% |
| Q2 FY2022 | Jul 1, 2022 | $0.26 | +52.9% |
| Q1 FY2022 | Apr 1, 2022 | $0.19 | +90.0% |
| Q4 FY2021 | Dec 31, 2021 | $0.10 | +42.9% |
| Q3 FY2021 | Oct 1, 2021 | $0.12 | +50.0% |
| Q2 FY2021 | Jul 2, 2021 | $0.17 | – |
| Q1 FY2021 | Apr 2, 2021 | $0.10 | – |
| Q4 FY2020 | Jan 1, 2021 | $0.07 | -50.0% |
| Q3 FY2020 | Oct 2, 2020 | $0.08 | +60.0% |
| Q2 FY2020 | Jul 3, 2020 | -$0.03 | -137.5% |
| Q1 FY2020 | Apr 3, 2020 | $0.00 | -100.0% |
| Q4 FY2019 | Jan 3, 2020 | $0.14 | +600.0% |
| Q3 FY2019 | Sep 27, 2019 | $0.05 | +66.7% |
| Q2 FY2019 | Jun 28, 2019 | $0.08 | +100.0% |
| Q1 FY2019 | Mar 29, 2019 | $0.03 | +200.0% |
| Q4 FY2018 | Dec 28, 2018 | $0.02 | – |
| Q3 FY2018 | Sep 28, 2018 | $0.03 | 0.0% |
| Q2 FY2018 | Jun 29, 2018 | $0.04 | – |
| Q1 FY2018 | Mar 30, 2018 | $0.01 | – |
| Q4 FY2017 | Dec 29, 2017 | $0.00 | – |
| Q3 FY2017 | Sep 29, 2017 | $0.03 | – |
| Q2 FY2017 | Jun 30, 2017 | -$0.02 | – |
| Q1 FY2017 | Mar 31, 2017 | -$0.05 | – |
| Q4 FY2016 | Dec 30, 2016 | $0.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?